If starting up a gliptin with a sulfonylurea, cutting down the dose of both drug could be required to minimise the potential risk of hypoglycaemia (see Dosing difficulties).Overall body weight substantially has an effect on the pharmacokinetics of liraglutide according to success of population pharmacokinetic analyses conducted in patients with sys